Rise in serious ADE reports in the US
Pfizer issues guidance on process impurity in Viracept
Important safety information highlighted for Fentora
Haloperidol labelling updated
New antidepressants linked to SGA neonates
CV disorder risks extend beyond COX-2-selectivity of NSAIDs
Intrauterine levonorgestrel plus transdermal estrogen is not associated with an increase in C-reactive protein (CRP) levels
Idraparinux effective, but risky, for venous thromboembolism
Signals from the US FDA AERS database
Pioglitazone, rosiglitazone face up to MI, HF risk analyses
Adverse event profile similar for drug-eluting and bare-metal stents
Alemtuzumab
Alemtuzumab/cyclophosphamide/fludarabine
Acetazolamide
Aripiprazole
Antineoplastics
Amiodarone interaction
Aspirin
Aripiprazole
Aspirin/clopidogrel/enoxaparin sodium
Benzalkonium chloride
Azathioprine
Bevacizumab
Bevacizumab
Bortezomib
Carbimazole/propylthiouracil/thiamazole
Bleomycin
Ciprofloxacin
Cefditoren pivoxil
Ciclosporin/mycophenolate mofetil/prednisone
Corticosteroids
Cotrimoxazole
Clodronic acid
Dexamethasone/diclofenac/paracetamol
Dasatinib
Dextromethorphan overdose/abuse
Cyclophosphamide
Erlotinib/gemcitabine
Erlotinib/gefitinib
Erlotinib
Exemestane/letrozole
Ethylmorphine hydrochloride/rocuronium bromide/suxamethonium chloride
Etanercept
Gadolinium-containing contrast agents
Flurbiprofen/ketoprofen
Fluorouracil
Gadoteridol
Ibuprofen
Ganciclovir
Herbal medicines
Imatinib
Imatinib
Immunoglobulins
Imatinib
Imatinib
Infliximab
Immunoglobulins
Immunoglobulins
Interferon-α-2b
Influenza virus vaccine
Iodine-131
Iohexol
Linezolid interaction
Lithium
Methotrexate interaction
Methotrexate
Nabumetone
Methylprednisolone/mycophenolate mofetil
Polymethyl methacrylate
Piribedil/pramipexole
Peginterferon/ribavirin
Rituximab
Royal jelly
Rituximab
Ranitidine
Sunitinib
Spironolactone
Sirolimus
Sildenafil
Vincristine
Vinorelbine
Voriconazole